MR-guided prostate interventions
- PMID: 18219689
- PMCID: PMC2683388
- DOI: 10.1002/jmri.21259
MR-guided prostate interventions
Abstract
In this article the current issues of diagnosis and detection of prostate cancer are reviewed. The limitations for current techniques are highlighted and some possible solutions with MR imaging and MR-guided biopsy approaches are reviewed. There are several different biopsy approaches under investigation. These include transperineal open magnet approaches to closed-bore 1.5T transrectal biopsies. The imaging, image processing, and tracking methods are also discussed. In the arena of therapy, MR guidance has been used in conjunction with radiation methods, either brachytherapy or external delivery. The principles of the radiation treatment, the toxicities, and use of images are outlined. The future role of imaging and image-guided interventions lie with providing a noninvasive surrogate for cancer surveillance or monitoring treatment response. The shift to minimally invasive focal therapies has already begun and will be very exciting when MR-guided focused ultrasound surgery reaches its full potential.
(Copyright) 2008 Wiley-Liss, Inc.
Figures











References
-
- Gray MA, Delahunt B, Fowles JR, Weinstein P, Cookes RR, Nacey JN. Demographic and clinical factors as determinants of serum levels of prostate specific antigen and its derivatives. Anticancer Res. 2004;24:2069–2072. - PubMed
-
- Powell IJ, Banerjee M, Novallo M, et al. Should the age specific prostate specific antigen cutoff for prostate biopsy be higher for black than for white men older than 50 years? J Urol. 2000;163:146, 148. discussion 148–149. - PubMed
-
- Efstathiou JA, Chen MH, Catalona WJ, et al. Prostate-specific antigen-based serial screening may decrease prostate cancer-specific mortality. Urology. 2006;68:342–347. - PubMed
-
- Cheng D, Tempany CM. MR imaging of the prostate and bladder. Semin Ultrasound CT MR. 1998;19:67–89. - PubMed
-
- Ellis JH, Tempany C, Sarin MS, Gatsonis C, Rifkin MD, McNeil BJ. MR imaging and sonography of early prostatic cancer: pathologic and imaging features that influence identification and diagnosis. AJR Am J Roentgenol. 1994;162:865–872. - PubMed
Publication types
MeSH terms
Grants and funding
- AG 19513/AG/NIA NIH HHS/United States
- R01 AG019513/AG/NIA NIH HHS/United States
- CA067165/CA/NCI NIH HHS/United States
- R01 CA109246/CA/NCI NIH HHS/United States
- RR 19703/RR/NCRR NIH HHS/United States
- P01 CA067165/CA/NCI NIH HHS/United States
- U41 RR019703/RR/NCRR NIH HHS/United States
- R01 CA104976/CA/NCI NIH HHS/United States
- CA111288/CA/NCI NIH HHS/United States
- U54 EB005149/EB/NIBIB NIH HHS/United States
- P41 RR019703/RR/NCRR NIH HHS/United States
- EB005149/EB/NIBIB NIH HHS/United States
- CA 104976/CA/NCI NIH HHS/United States
- CA 109246/CA/NCI NIH HHS/United States
- R01 CA111288/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical